Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check3 days agoChange DetectedThe page’s Revision identifier was updated from v3.6.2 to v3.6.3, reflecting a newer version of the page. This appears to be an internal versioning update rather than a change to the study details or user-facing content.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This reflects a newer patch level of the document rather than content changes.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status on the study page now indicates enrollment is closed. The page also adds new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0, with a minor formatting change to the Intervention/Treatment header.SummaryDifference0.3%

- Check32 days agoChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5, indicating a version upgrade.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision tag was updated to v3.5.4, replacing the previous v3.5.3. This denotes a minor page update without altering the study content or public details.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.